NACC1

Chr 19

nucleus accumbens associated 1

Also known as: BEND8, BTBD14B, BTBD30, NAC-1, NAC1, NECFM

This gene encodes a member of the BTB/POZ protein family. BTB/POZ proteins are involved in several cellular processes including proliferation, apoptosis and transcription regulation. The encoded protein is a transcriptional repressor that plays a role in stem cell self-renewal and pluripotency maintenance. The encoded protein also suppresses transcription of the candidate tumor suppressor Gadd45GIP1, and expression of this gene may play a role in the progression of multiple types of cancer. A pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Feb 2012]

ResearchGenerating clinical summary…
GOFmechanismLOEUF 0.17
Clinical SummaryNACC1
🧬
Gene-Disease Validity (ClinGen)
NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 206 VUS of 509 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.17LOEUF
pLI 0.998
Z-score 3.90
OE 0.00 (0.000.17)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.17Z-score
OE missense 0.39 (0.340.45)
143 obs / 367.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.17)
00.351.4
Missense OE?0.39 (0.340.45)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 0 / 17.7Missense obs/exp: 143 / 367.9Syn Z: 0.35
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveNACC1-related infantile epilepsy, cataracts, and profound developmental delayGOFAD

This gene — mechanism propensity

DN
0.2698th %ile
GOF
0.3094th %ile
LOF
0.83top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · LOEUF 0.17

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

509 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic4
VUS206
Likely Benign217
Benign60
Conflicting16
2
Pathogenic
4
Likely Pathogenic
206
VUS
217
Likely Benign
60
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
0
0
2
Likely Pathogenic
0
4
0
0
4
VUS
8
185
9
4
206
Likely Benign
0
13
38
166
217
Benign
0
32
11
17
60
Conflicting
16
Total823658187505

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

23 pathogenic / likely-pathogenic (of 33) ClinVar copy-number / structural variants overlap NACC1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NACC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →